title: Pediatric allergic rhinitis.
abstract: Allergic rhinitis is a common pediatric problem with significant comorbidities and potential complications. This article is an overview of the epidemiology, pathophysiology, and current therapeutic strategies. Allergic rhinitis management in a specific child is age dependent and influenced by the severity and frequency of the symptoms and the presence of any concurrent conditions. Current strategies permit symptomatic control and improved quality of life for most patients.
authors.affiliation: Division of Clinical Immunology and Allergy, Department of Medicine, The University of Mississippi Medical Center, 768 Lakeland Drive, Building LJ, Jackson, MS 39216, USA.
authors.forename: Chet A
authors.initials: CA
authors.lastname: Tharpe
authors.affiliation: Division of Clinical Immunology and Allergy, Department of Medicine, The University of Mississippi Medical Center, 768 Lakeland Drive, Building LJ, Jackson, MS 39216, USA. Electronic address: skemp@umc.edu.
authors.forename: Stephen F
authors.initials: SF
authors.lastname: Kemp
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001249:Asthma / Q000150:complications* / Q000628:therapy; D002648:Child; D003231:Conjunctivitis / Q000150:complications / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab; D011788:Quality of Life; D065631:Rhinitis, Allergic / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D012852:Sinusitis / Q000150:complications
chemical_list: D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E
keywords: Allergic rhinitis; Avoidance; Concurrent conditions; Conjunctivitis; Immunomodulation; Pharmacotherapy